Eledon Pharmaceuticals, Inc. (ELDN) Reports In-Line Q3 EPS

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q3 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• Waymo Explores Split With Uber - FT
• McGraw Hill (MH) files for 165M share offering by selling stockholders
• Freedom Broker Downgrades Gentherm Incorporated (THRM) to Hold